Autopsy report · NCT02021929
Sorafenib for Hepatopulmonary Syndrome
Cause of deathNo reason given
Life of this trial
- Registered 3 months before it started.
- Ran for about 3 years 10 months before it stopped.
- 28 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Conditions
- Hepatopulmonary Syndrome
- Interventions
- Sorafenib; Placebo
- Participants
- 28
- Sites
- 7
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.